Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Iterum Therapeutics Plc (ITRM)  
$1.52 0.03 (1.94%) as of 4:30 Mon 5/13


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 13,960,000
Market Cap: 21.22(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.6501 - $2.3
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Iterum Therapeutics is a clinical-stage pharmaceutical company focused on developing and commercializing sulopenem oral to be an oral penem available in the U.S. and an oral and intravenous (IV) branded penem available globally. The objective of Co.'s sulopenem program is to deliver to patients an oral and IV formulation of sulopenem approved in the U.S. and Europe for the treatment of infections due to resistant gram-negative pathogens. Co. has also developed sulopenem in an oral tablet formulation, sulopenem etzadroxil-probenecid.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 65,000 65,000 75,000
Total Buy Value $0 $109,995 $109,995 $132,195
Total People Bought 0 2 2 2
Total Buy Transactions 0 4 4 5
Total Shares Sold 0 0 0 118,909
Total Sell Value $0 $0 $0 $243,022
Total People Sold 0 0 0 2
Total Sell Transactions 0 0 0 10
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 102
  Page 2 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Ahrens Brenton Karl Director   –       •      –    2022-09-15 4 S $2.02 $30,272 I/I (15,000) 37,246 40%     
   Ahrens Brenton Karl Director   –       •      –    2022-09-14 4 S $2.10 $31,457 I/I (15,000) 52,246 43%     
   Ahrens Brenton Karl Director   –       •      –    2022-09-13 4 S $2.14 $32,118 I/I (15,000) 67,246 44%     
   Ahrens Brenton Karl Director   –       •      –    2022-09-12 4 S $2.31 $34,608 I/I (15,000) 82,246 48%     
   Ahrens Brenton Karl Director   –       •      –    2022-09-09 4 S $2.32 $34,730 I/I (15,000) 97,246 50%     
   Ahrens Brenton Karl Director   –       •      –    2022-09-08 4 S $2.26 $7,465 I/I (3,298) 112,246 48%     
   Dunne Michael W. Director   –       •      –    2022-09-07 4 B $2.22 $22,200 D/D 10,000 35,576 2.39 -46%     
   Hecht Beth Director   –       •      –    2022-06-23 4 OE $0.00 $0 D/D 36,798 44,805     -
   Dunne Michael W. Director   –       •      –    2022-06-23 4 OE $0.00 $0 D/D 36,798 383,647     -
   Hunt Ronald Director   –       •      –    2022-06-23 4 OE $0.00 $0 D/D 36,798 42,501     -
   Chin Mark Director   –       •      –    2022-06-23 4 OE $0.00 $0 D/D 36,798 36,798     -
   Dunne Michael W. Director   –       •      –    2022-03-25 4 OE $0.00 $0 D/D 10,494 346,849     -
   Hecht Beth Director   –       •      –    2022-03-18 4 OE $0.00 $0 D/D 7,642 8,007     -
   Matthews Judith M. Chief Financial Officer   •       –      –    2022-03-14 4 S $0.38 $17,910 D/D (47,132) 81,500 34%     
   Matthews Judith M. Chief Financial Officer   •       –      –    2022-03-14 4/A S $0.31 $19,635 D/D (63,340) 65,292     -
   Fishman Corey N. Chief Executive Officer   •       •      –    2022-03-11 4 OE $0.00 $0 D/D 215,000 537,008     -
   Matthews Judith M. Chief Financial Officer   •       –      –    2022-03-11 4 A $0.00 $0 D/D 100,000 128,632     -
   Dunne Michael W. Director   –       •      –    2021-07-25 4 A $0.00 $0 D/D 80,000 336,355     -
   Sarissa Capital Master Fund Ii Lp 10% Owner   –       –       •   2021-02-12 4 S $2.27 $24,107,284 I/I (10,619,949) 0 10%     
   Sarissa Capital Master Fund Ii Lp 10% Owner   –       –       •   2021-02-11 4 S $2.59 $25,900,000 I/I (10,000,000) 10,619,949 14%     
   Sarissa Capital Master Fund Ii Lp 10% Owner   –       –       •   2021-02-11 4 A $0.00 $0 I/I 20,619,949 20,616,949     -
   Shah Rajeev M. 10% Owner   –       –       •   2021-02-04 4 A $0.00 $0 I/I 11,651,597 11,651,597     -
   Matthews Judith M. Chief Financial Officer   •       –      –    2021-01-26 4 S $1.73 $58,592 D/D (33,868) 28,632 -6%     
   Fishman Corey N. President & CEO   •       •      –    2021-01-26 4 S $1.73 $147,820 D/D (85,445) 322,008 -6%     
   Dunne Michael W. Director   –       •      –    2021-01-26 4 S $1.73 $57,337 D/D (33,143) 256,355 -6%     
  102 Records found
  1  2  3  4  5   
  Page 2 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us